ERCC2

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, ERCC2 mutation is significantly associated with the RNA expression of many other genes, with 2,242 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible ERCC2-associated genes across cancer lineages are TRAJ21, ALAS1, and FANCD2. Each is linked with ERCC2 in more than 2 cancer types. Because this analysis shows association rather than direction, both ERCC2-to-partner and partner-to-ERCC2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, TRAJ21 grouped by ERCC2-low versus ERCC2-high in PRAD.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ERCC2→partner) and Y-score (partner→ERCC2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
PRADTRAJ21 →+0.557+4.721<.001.00733
UCECALAS1 →+0.521+3.708.002<.00133
UCECFANCD2 →+0.654+3.721<.001<.00133
COADPGAM1P6 →+0.200+4.011.008.00133
LIHCOR6R2P →+0.146+3.481<.001.00832
BRCARNA5SP147 →+0.247+5.324<.001.00332
Each partner links to its Q-omics profile. Showing the 6 strongest of 2,242 associations by consensus.

TRAJ21 by ERCC2 expression — PRAD

Box plot of TRAJ21 in ERCC2-low vs ERCC2-high samples in PRAD.

Explore this box plot interactively →

Exploration